AAVantgarde Bio Srl

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, AAVantgarde Bio Srl sits in the upper half of US sponsors by registered trial count (#4,885 of 15,742 sponsors by registered trial count).

2 total trials 2 currently recruiting early-phase tilt upper half by trial count

AAVantgarde Bio Srl: 2 sponsored US clinical trials, 2 recruiting.

AAVantgarde Bio Srl sponsors 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stargardt Disease, with 2 trials.

Mid-pack sponsor footprint

AAVantgarde Bio Srl is in the upper half of sponsors by trial count (#4,885 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

What is open in the AAVantgarde Bio Srl pipeline

2 recruiting of 2 indexed (100% open).

Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).

Top condition: Stargardt Disease (2 trials), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

AAVantgarde Bio Srl: open-pipeline peers nationwide

Peers matched on 2 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

AAVantgarde Bio Srl sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1.522.533.544.5 0%50%100%150% Total trials Recruiting share AAVantgarde Bio Srl1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAcorn BiolabsAcrivon TherapeuticsADARx PharmaceuticalsAdcendo ApS
AAVantgarde Bio Srl sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

AAVantgarde Bio Srl sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 2 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

What to do with this AAVantgarde Bio Srl page

2 registered trials is a research-attention snapshot, not an endorsement of AAVantgarde Bio Srl or any single study.

  • 2 of AAVantgarde Bio Srl's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Stargardt Disease is the condition AAVantgarde Bio Srl studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stargardt Disease trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

AAVantgarde Bio Srl pipeline card: 2 registered trials from official public datasets.Report a data error.